Medication and Medical Therapy: Accreditation and Protocols
Medical therapy for hair loss—primarily finasteride and minoxidil—represents a common first-line approach for many patients seeking to address pattern.
Last reviewed: 2026-05-06
13 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Key takeaways
Board certification (ABHRS) and ISHRS membership are key credentials to verify before choosing a hair loss medication provider.
Finasteride (1mg) and minoxidil (2%/5%) are FDA-approved for pattern hair loss; compounded versions carry additional risks.
The MHRA (UK) and other regulatory bodies have issued recent safety alerts about finasteride psychiatric and sexual side effects.
Always request a documented treatment protocol and monitoring plan before starting any prescription hair loss medication.
International patients should confirm medication legality in their home country and plan for ongoing monitoring after returning home.
Understanding Medical Therapy Accreditation and Protocols
Medical therapy for hair loss—primarily finasteride and minoxidil—represents a common first-line approach for many patients seeking to address pattern hair loss. These medications may be effective for some individuals, but their safety and outcomes depend significantly on who prescribes them, how they are monitored, and whether patients understand the potential risks involved. For international patients traveling to Istanbul for hair restoration, understanding accreditation standards and treatment protocols is essential for making informed decisions about their care.
The core principle is straightforward: the quality of your outcome depends significantly on the qualifications of the provider managing your care. This is particularly true for medical therapies, where prescriptions are written with limited ongoing supervision in some settings. Understanding what credentials mean, what regulatory approvals exist, and what questions to ask can help you separate qualified providers from those prioritizing sales over patient safety.
For patients exploring their options, the Hair Resources Hub provides additional context on the full range of hair restoration approaches, while Hair Treatment Options covers both medical and surgical pathways.
What Makes a Provider Qualified to Prescribe Hair Loss Medications
International Certification Bodies
The American Board of Hair Restoration Surgery (ABHRS) is the only board certification specifically designed for hair restoration surgeons. According to ABHRS certification requirements, candidates must demonstrate completed training, post-training experience, and successful completion of both written and oral examinations S5. This certification represents the most rigorous standard for hair restoration physicians in the United States and internationally.
The International Society of Hair Restoration Surgery (ISHRS) publishes FUE Clinical Practice Guidelines, Core Curriculum, and Core Competencies that establish international standards for hair restoration procedures S1. These guidelines cover both surgical and medical aspects of hair loss treatment, providing a framework that qualified providers typically follow.
Board Certification vs. Membership
An important distinction exists between board certification and society membership. ABHRS certification requires passing rigorous examinations and meeting experience thresholds—it is an earned credential. ISHRS membership, while valuable and indicating professional interest in hair restoration, does not itself certify competence. Patients should verify credentials through official certification bodies rather than relying on marketing materials or website claims S1.
How to Verify Provider Credentials
Before committing to any provider, take these verification steps:
Request certification numbers - Ask for ABHRS certification ID and verify through the official ABHRS website
Confirm ISHRS membership status - Check the ISHRS member directory
Request before/after documentation - Qualified providers maintain clinical photo records
Ask about their specific experience - How many patients have they managed on finasteride or minoxidil? What protocols do they use?
Inquire about follow-up care - How will they monitor your progress and manage side effects?
When choosing a hair restoration provider, the verification process should include these steps to ensure you work with a qualified professional.
The Regulatory Landscape for Hair Loss Medications
FDA-Approved vs. Off-Label Uses
Finasteride at 1mg (brand name Propecia) is FDA-approved for male pattern hair loss in men aged 18-41 S2. This approval specifically covers the treatment of androgenetic alopecia (male pattern baldness). At higher doses (5mg), finasteride is approved for benign prostatic hyperplasia (BPH) under the brand name Proscar.
Minoxidil at both 2% and 5% concentrations is FDA-approved for both men and women, available in both liquid and foam formulations S2. It is indicated for the treatment of androgenetic alopecia and works by increasing blood flow to hair follicles, potentially prolonging the anagen (growth) phase.
The ISHRS Medical Treatments Information resource provides detailed protocols for both medications, including application guidelines, expected timelines, and monitoring recommendations S2.
Compounded Medications - What Patients Should Know
Compounded topical finasteride products have NOT received FDA approval and have been subject to safety alerts. In April 2025, the FDA issued guidance addressing reports of adverse events associated with compounded topical finasteride, including sexual dysfunction and psychiatric effects S3. These products may have variable concentrations and purity levels that differ from FDA-approved formulations.
Key concerns with compounded medications include:
Variable potency - Concentrations may not be consistent across batches
Lack of FDA oversight - Quality control standards differ from approved pharmaceuticals
Limited safety data - Adverse event tracking is less comprehensive
Regulatory ambiguity - Status may vary by jurisdiction
Patients should specifically ask whether any prescribed finasteride is FDA-approved or compounded, and understand the implications of each.
International Regulatory Differences
Regulatory status varies significantly by country. In the UK, finasteride for hair loss is typically available via private prescription only—not NHS-funded S4. The UK Medicines and Healthcare products Regulatory Agency (MHRA) issued a 2024 safety alert requiring patient alert cards for finasteride due to psychiatric and sexual side effect risks S3.
For international patients, key considerations include:
Medication legality - Confirm whether prescribed medications are legal in your home country
Customs regulations - Some countries restrict importation of certain medications
Prescription recognition - Will your home-country physician honor an international prescription?
Follow-up access - How will you obtain refills and monitoring after returning home?
Key Questions to Ask Your Provider
About Their Credentials and Experience
Are you board certified by the ABHRS?
How long have you been prescribing finasteride and minoxidil?
How many patients are you currently managing on these medications?
What monitoring protocol do you use?
How do you handle patients who experience side effects?
About the Medications They Prescribe
Is the finasteride you prescribe FDA-approved or compounded?
What concentration and formulation do you recommend?
Are there any alternative medications we should consider?
What results can I realistically expect, and in what timeframe?
What happens if this medication does not work for me?
About Monitoring and Follow-Up
How often will I need follow-up appointments?
What tests or assessments will you conduct?
How should I report side effects?
What is your protocol if I experience psychiatric symptoms?
Will I have access to telehealth follow-up after I return home?
Understanding Medical Therapy Protocols
Finasteride Treatment Guidelines
Finasteride works by inhibiting 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT is implicated in miniaturization of hair follicles in genetically susceptible individuals.
Standard finasteride protocol considerations include:
Dosage: 1mg daily for androgenetic alopecia (higher doses used for BPH)
Expected timeline: Effects typically become visible at 3-6 months, with optimal results at 12+ months
Monitoring: Regular check-ins to assess efficacy and side effects
Duration: Treatment must typically continue to maintain results
Minoxidil Treatment Protocols
Minoxidil is a topical vasodilator that may prolong the anagen (growth) phase of hair follicles and increase blood flow to the scalp.
Standard minoxidil protocol considerations include:
Application: Typically twice daily for liquid formulation, once daily for foam
Expected timeline: Initial shedding may occur in weeks 2-8; visible improvement at 3-6 months
Skin tolerance: Monitor for irritation, especially with liquid formulation
Continuation: Effects reverse if medication is discontinued
PRP Treatment Protocols and Medical Supervision
Platelet-Rich Plasma (PRP) therapy for hair loss involves drawing the patient's blood, processing it to concentrate platelets, and injecting the plasma into the scalp. This medical procedure requires appropriate clinical setting and medical supervision S2.
Key PRP standards include:
Medical setting requirement - PRP should be administered in a proper clinical environment with appropriate infection control
Physician oversight - A qualified physician should oversee the procedure and manage any adverse reactions
Blood handling protocols - Proper centrifugation and handling according to established medical standards
Informed consent - Patients should understand the experimental nature of PRP for hair loss in some jurisdictions
It is important to note that PRP for hair restoration is considered investigational by some regulatory bodies and should be discussed as an adjunct therapy rather than a replacement for FDA-approved medications.
Documentation and Consent Standards
What Documentation You Should Receive
Qualified providers should provide the following documentation before starting treatment:
Written treatment protocol - Detailed instructions for medication use, including dosage, timing, and application methods
Monitoring schedule - Clear timeline for follow-up appointments and assessments
Side effect information - Comprehensive list of potential side effects with guidance on when to seek help
Emergency contact information - Clear instructions on who to contact if concerning symptoms arise
Medication information leaflet - Official prescribing information for any prescribed medications
Consent Standards
Before starting any prescription hair loss medication, you should expect:
Medical history review - Provider should ask about your complete medical history, including psychiatric history
Medication reconciliation - Discussion of all medications and supplements you are taking
Discussion of alternatives - Information about other treatment options available
Risk disclosure - Clear explanation of known risks and uncertainties
Written consent - Documentation that you understand the risks and consent to treatment
Recognizing and Managing Side Effects
Common Side Effects and Self-Monitoring
Both finasteride and minoxidil have documented side effect profiles that patients should understand before starting treatment:
Finasteride common effects (may affect up to 10% of users):
Decreased libido
Erectile dysfunction
Ejaculation disorders
Minoxidil common effects:
Scalp irritation or dryness
Increased facial hair growth (particularly with 5% formulation)
Temporary shedding in first 2-8 weeks (this is a common early response that some patients experience)
Serious Side Effects Requiring Immediate Attention
The MHRA 2024 safety alert emphasized that psychiatric and sexual side effects can persist after stopping finasteride S3. Yellow Card reporting data shows 281 reports of psychiatric effects and 426 reports of sexual dysfunction to the UK MHRA as of April 2024 S3.
Seek immediate medical attention for:
Depression or mood changes
Suicidal thoughts or ideation
Persistent sexual dysfunction after discontinuation
Severe skin reactions
Chest pain or heart palpitations
When to Seek Medical Guidance
Individual responses to these medications vary. Discontinue use and contact a healthcare provider promptly if you experience:
Any psychiatric symptoms including depression, anxiety, or suicidal thoughts
Persistent sexual side effects that continue after stopping the medication
Significant skin reactions or allergic responses
Any other symptoms that concern you
Your provider can help you weigh potential benefits against risks based on your personal medical history and determine whether continued treatment is appropriate for your situation S4.
The NHS finasteride information page provides additional context on side effect management and when to seek medical help S4.
Important Safety Information
Finasteride should never be handled by pregnant women due to the risk of birth defects. If you have a female partner who is or may become pregnant, take precautions to prevent exposure. Additionally, patients experiencing any adverse effects should report them to appropriate regulatory bodies such as FDA MedWatch in the United States or MHRA Yellow Card in the United Kingdom.
Red Flags - Recognizing Unsafe Practices
Consumer Alerts Regarding Unlicensed Technicians
The ISHRS has issued consumer alerts warning about practices where unlicensed technicians perform procedures that require physician training and judgment S1. Patients should understand that certain aspects of hair restoration should only be performed by qualified physicians, not delegated to technicians without appropriate supervision or training.
Marketing Claims That Should Raise Concerns
Marketing materials making unrealistic guarantees, claiming "zero risk," or offering significantly discounted procedures compared to market rates may indicate problematic practices. Legitimate providers typically present realistic expectations and appropriate pricing based on clinical standards.
Facility and Procedural Warning Signs
Red Flags
Provider who guarantees results or claims "zero risk"
No clear answer about whether medications are FDA-approved
Refusal to provide written treatment protocols
No follow-up plan or monitoring schedule
Pressure to commit before asking about your medical history
No clear escalation path if you experience side effects after returning home
Facilities lacking appropriate accreditation, unable to provide clear documentation of credential verification, or unwilling to answer questions about their procedures may warrant caution.
Action Checklist for Safe Medical Therapy
Before Starting Treatment
[ ] Verify provider credentials through official certification bodies (ABHRS, ISHRS)
[ ] Request detailed information about whether medications are FDA-approved or compounded
[ ] Discuss personal and family medical history, particularly psychiatric conditions
[ ] Understand the complete side effect profile, including potential persistence
[ ] Confirm how you will be monitored during treatment
[ ] Establish a clear plan for follow-up after returning home
[ ] Verify medication legality in your home country
During Treatment
[ ] Track any side effects, even mild ones, in a journal
[ ] Attend all scheduled follow-up appointments (in-person or telehealth)
[ ] Report concerning symptoms immediately—do not wait for scheduled appointments
[ ] Keep a list of all medications you are taking to discuss potential interactions
[ ] Understand what to do if you need to discontinue treatment suddenly
Planning for Follow-Up Care
If you are traveling internationally for treatment, plan how follow-up care will be managed after you return home. Establish clear communication channels with your provider and understand when to seek urgent medical attention. Having an escalation plan in place supports prompt response to any safety concerns.
Understanding Treatment Timelines
Having realistic expectations about treatment timelines is important for informed decision-making:
3-6 months: Many patients begin to see visible improvement, though individual response varies
12+ months: Optimal treatment outcomes are often achieved by this point
Ongoing: Continued treatment is typically necessary to maintain results
Some individuals may be non-responders to certain medications, and response varies significantly between patients based on factors including genetics, the specific pattern of hair loss, and adherence to treatment protocols S2. Your provider should discuss this possibility during your consultation.
Educational only (not medical advice)
Starting medical therapy for hair loss is a significant decision that affects your health and wellbeing. The right provider will welcome your questions, verify their credentials transparently, and prioritize your long-term safety over a quick prescription.
Start Your Plan with our care coordination team to connect with qualified providers who meet international standards for hair loss medication management. We will help you verify credentials, understand treatment protocols, and coordinate your care from consultation through follow-up.
